Nyumbani › Saratani ya Mkojo › Washington › Seattle
Majaribio ya kliniki ya Saratani ya Mkojo katika Seattle, WA
Masomo 21 ya Saratani ya Mkojo yanatafuta washiriki katika vituo vya Seattle na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- na zaidi ya 1
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
InaajiriHatua 2
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
InaajiriHatua 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
InaajiriHatua 1/2
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- na zaidi ya 3
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
InaajiriHatua 1
- Swedish Cancer Institute, Seattle
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
InaajiriHatua 3
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
InaajiriHatua 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Inaajiri
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
InaajiriHatua 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
InaajiriUtafiti wa uchunguzi
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
InaajiriHatua 2/3
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
InaajiriHatua 2
- University of Washington School of Medicine, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
InaajiriHatua 3
- Research Site, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
InaajiriHatua 2
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Inaajiri
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
InaajiriHatua 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
InaajiriHatua 1
- Fred Hutchinson Cancer Center, Seattle
Blue Light Cystoscopy With Cysview® Registry
InaajiriUtafiti wa uchunguzi
- University of Washington Medicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
InaajiriUtafiti wa uchunguzi
- Massive Bio SYNERGY-AI site, Seattle
Majaribio ya Saratani ya Mkojo katika miji mingine
- New York City, NYUtafiti 35
- Nashville, TNUtafiti 31
- Houston, TXUtafiti 31
- Dallas, TXUtafiti 27
- Boston, MAUtafiti 26
- Washington, DCUtafiti 26
- Los Angeles, CAUtafiti 24
- Baltimore, MDUtafiti 24
- St. Louis, MOUtafiti 22
- Philadelphia, PAUtafiti 21
- Edison, NJUtafiti 21
- Chicago, ILUtafiti 21
Masomo mengine katika Seattle
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 53
- Saratani (aina zote)Utafiti 49
- Saratani ya ProstateUtafiti 42
- Leukemia ya Myeloid ya GhaflaUtafiti 40
- Saratani ya MatitiUtafiti 39
- Saratani ya MetastasiUtafiti 39
- Kansari ya kolorektaliUtafiti 34
- Saratan ya MapafuUtafiti 33
- Kansari ya MayaiUtafiti 30
- Multiple MyelomaUtafiti 22
- Sindromu za MyelodysplasticUtafiti 21
- Leukemia ya Lymphoblastic ya GhaflaUtafiti 21
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.